Halvorsen & Reith

Economic substance filing review for cross-border groups

An economic substance filing review checks whether a company's activity in its jurisdiction of incorporation matches what the corporate registry, the tax authority and any counterparty checking the register will expect to find. Cross-border groups commission the review when a subsidiary's core income-generating activity moves, when a director resigns, or when a corporate services provider raises the question before the group has an answer of its own. The output is a documented position the board can adopt and defend, not a form completed on assumption.

A holding company with one director resident abroad and a registered office it has never visited receives a routine substance questionnaire from the registrar. The finance director assumes the local corporate services provider already handles it. Nobody has confirmed for two reporting cycles whether board decisions are actually taken where the company is incorporated, or whether that fact changes the entity's classification under local company law.

This page sets out when that review becomes necessary, what it produces, and where the advisory work stops.

The situation an economic substance filing review addresses

Substance rules apply to a defined list of activities carried on by companies incorporated in a jurisdiction other than the one where the parent or the operating business is managed: holding company business, intellectual property holding, finance and leasing, fund management, shipping, and headquarters or distribution activity among the most common. A cross-border structure running any of these through a subsidiary is the structure this review is built to check, because the regulatory exposure sits with the entity, not with the group as a whole.

A group that has already confirmed its position for one entity in Abu Dhabi Global Market still needs a separate answer for every other entity, because the test applies entity by entity and not group by group. The question sits next to, but is not identical to, a management and control review: substance asks whether the activity is genuinely carried on locally, control asks where decisions are actually taken, and a group frequently needs both answers before it can sign off either one.

What triggers the need for economic substance filing review, and why timing matters

Four events usually put the question on the table. A director resigns or is replaced and nobody has confirmed whether the replacement satisfies the board test the entity relies on. The group relocates the function that generates the entity's income, whether that is contract negotiation, asset management or a licensing decision. A new entity is incorporated into the structure and inherits the parent's assumptions rather than answering the question for itself. Or a bank, an auditor or a counterparty asks directly, and the group discovers it has never written the answer down.

The confirmation period for most substance regimes runs from the entity's financial year end, an event a group without a substance calendar often does not track. Once that period closes without a filed position, the classification for that reporting period becomes fixed on the register and can only be corrected going forward, never withdrawn.

The same logic applies to related filings elsewhere. A company that misses successive annual filings can be struck off the register before anyone notices, a consequence set out in the context of late filings in Belgium, and a missed regulatory filing on the substance side rarely arrives alone; it compounds the exposure rather than sitting separately from it.

What the work produces, in sequence

The review is sequenced so that each step is usable on its own if the group stops there.

First, a classification memorandum sets out which relevant activity, if any, the entity carries on, tested against the entity's actual income and the assets behind it, not against its stated purpose. Second, a substance matrix maps board composition, meeting location, adequate employees and expenditure, and premises against the test the entity's jurisdiction applies, entity by entity where the group holds more than one. Where the entity's constitutional documents restrict where the board may meet or who may sign on its behalf, that restriction is checked before the matrix is finalised, not after.

Third, marked-up board minutes and a resolution template give the board the document trail the test actually asks for, addressing the question of which resolutions a substance filing review requires rather than leaving it to the company secretary to guess. Where the meeting format itself is in question, the position is checked against the comparison of physical, hybrid and written board meetings, because a written resolution passed by directors who never meet is not evidence of local substance on most tests. Fourth, a board pack sets out the group's position, the open points still outstanding, and the filing-ready draft the board is asked to adopt before the return is submitted.

A group carrying that exposure into a new financial year without having confirmed even one entity's classification is carrying it past the point where the position can still be set on the group's own schedule.

Check what your jurisdiction requires. Write to info@hreithlaw.com with the jurisdiction and the structure.

Where economic substance filing review differs by jurisdiction

The activities caught, the adequacy test applied to employees and expenditure, and the confirmation cycle itself differ by jurisdiction, and a group operating across several centres cannot assume the same calendar or the same test applies twice. Some jurisdictions test the entity against a narrowly defined list of qualifying activities; others apply a broader facts-and-circumstances test that leaves more room for argument, and more room for a wrong assumption. A registered office that satisfies one jurisdiction's requirement for a physical presence will not automatically satisfy another's, and regulatory exposure is assessed jurisdiction by jurisdiction, never against a single group-wide standard.

Where a jurisdiction's confirmation cycle runs on the calendar year rather than the entity's financial year, a group that files by financial year elsewhere misses the local deadline without ever missing its own, and the local classification is set before the group's own year end arrives. This review is run across the jurisdictions in which the group holds a relevant entity; coverage is confirmed at the outset of each engagement rather than assumed from the jurisdiction where the parent sits.

What this service does not include

This engagement does not include acting as, supplying, sourcing or arranging a director, secretary, nominee shareholder or trustee for any entity in the structure, and it does not include any activity for which a trust or corporate service provider licence is required. That boundary is set by licensing law in the jurisdictions where the firm advises, not by the scope the firm would otherwise choose to offer, and it holds regardless of how the structure's company law happens to be organised.

What the client receives instead is the requirement mapped against the entity's actual facts, the test criteria set out in a form the board can apply itself, the existing appointment terms of any director or officer reviewed against what the substance test expects of them, and the group's regulatory exposure assessed before a regulator or a bank raises the question. Where the structure needs a person appointed to satisfy a board or presence test, that appointment is arranged by the client or by a licensed provider, and the review is written so that either can act on it directly.

Check what your jurisdiction requires. Write to info@hreithlaw.com with the jurisdiction and the structure.

Frequently asked questions

What does an economic substance filing review actually involve?
It involves testing the entity's real activity, board composition and premises against the jurisdiction's own criteria, not against a general description of what the group does. The output is a written position the board adopts, together with the matrix and minutes that support it if the position is later questioned.
Who inside the company is responsible for the filing itself?
The board is responsible, not the company secretary or the corporate services provider who submits the form on the board's instruction. A director who signs the annual return without having seen the classification memorandum is signing something that has not actually been tested.
What evidence should the board keep once the filing is made?
The classification memorandum, the matrix and the minutes recording the board's own decision, kept together rather than filed separately from the return. A filing without the reasoning behind it is difficult to defend a year later, once the director who made the decision may no longer sit on the board.
What happens if the question is never addressed?
The common assumption is that a substance filing is a formality the corporate services provider handles on autopilot. It is not: an unaddressed classification stands until a regulator, a bank or an auditor tests it, at which point the group answers under time pressure rather than on its own schedule.
How often does this need to be revisited?
At minimum once a year, aligned to the entity's financial year end, and immediately whenever a director changes, an activity moves, or a new entity is added to the structure. Waiting for the annual cycle to catch a mid-year change is how the classification and the underlying facts drift apart.

Sanne Dekker, expert author. Sanne Dekker advises cross-border groups on economic substance classification, board governance and the interaction between the two. Her work centres on structures spanning offshore holding jurisdictions and the operating businesses that sit above them. She writes on the governance consequences of substance testing rather than the tax analysis that usually accompanies it.

By Jonas Kittel